Trials / Completed
CompletedNCT02511561
OTO-201 for the Treatment of Otitis Externa
A 1-Month, Prospective, Multicenter, Open-Label Study of OTO-201 Given as a Single Administration for Treatment of Otitis Externa
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Otonomy, Inc. · Industry
- Sex
- All
- Age
- 6 Months – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a 1-month, multicenter, open-label study in subjects with unilateral otitis externa. Eligible subjects will receive a single dose of 6 mg OTO-201 to the affected ear. The study is designed to characterize safety, procedural factors and clinical effect of OTO-201 administered in subjects with otitis externa.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OTO-201 (ciprofloxacin) |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2015-07-30
- Last updated
- 2020-10-19
- Results posted
- 2020-09-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02511561. Inclusion in this directory is not an endorsement.